Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yoko Suehiro
Correction To: Multicenter Phase 1/2 Study of Forodesine in Patients With Relapsed Peripheral T Cell Lymphoma
Annals of Hematology
Medicine
Hematology
Related publications
Forodesine in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma: An Evidence-Based Review
OncoTargets and Therapy
Oncology
Pharmacology
Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Tipifarnib in Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (Aitl) and Cxcl12+ Peripheral T-Cell Lymphoma (Ptcl): Preliminary Results From a Phase 2 Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase 1 Study of Pralatrexate Plus Romidepsin Reveals Marked Activity in Patients With Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (Ptcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Outcome of Patients With Relapsed and Refractory Peripheral T Cell Lymphoma Intended for Stem Cell Transplant
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Combination of Chidamide With Choep Regimen in Previously Untreated Patients With Peripheral T-Cell Lymphoma: A Prospective, Multicenter, Single-Arm, Phase 1b/2 Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Interim Update From a Phase 2 Multicenter Study of Tazemetostat, an Ezh2 Inhibitor, in Patients With Relapsed or Refractory Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase 1/1b Dose-Escalation Trial Evaluating Cpi-818, an Oral Interleukin-2-Inducible T-Cell Kinase Inhibitor, in Patients With Relapsed/Refractory T-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Autologous Stem Cell Transplantation as Part of First-Line Therapy in Patients With Peripheral T-Cell Lymphoma: A Multicenter Geltamo/Fil Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology